Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

Role of Early Arterial Phase Imaging in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

Liver cirrhosis is a common consequence of chronic liver disease, resulting from sustained hepatic injury due to various etiologies. Cirrhosis predisposes individuals to the development of hepatocellular carcinoma (HCC), the most prevalent primary malignancy of the liver. Among cirrhotic patients, distinguishing between hepatocellular carcinoma and dysplastic nodules is crucial for timely diagnosis, treatment planning, and prognostic assessment.

Inclusion Criteria:

• Patients with abnormal LFTs
• Liver lesions of various sizes
• Patients with chronic liver disease
• Individuals undergoing routine liver screening
• Willing participants who consent to the study

Exclusion Criteria:

• Children less than 5years
• Patients who are allergic or have a history of allergy to contrast media
• Patients with deranged renal function tests
• Pregnant women